Phychem Technology Pvt Ltd sees Rs 18.1585 crore funding gap

Phychem Technology Pvt Ltd forecasts an Rs 18.1585 crore working-capital gap in Fiscal 2027, against an actual restated Rs 12.4819 crore in Fiscal 2026. The estimate combines 40 days of customer credit, 25 days to pay suppliers and Rs 3 crore of proposed IPO proceeds for working-capital requirements.

Why does Phychem’s Fiscal 2027 working-capital gap rise to Rs 18.1585 crore?

Phychem’s Fiscal 2027 working-capital gap rises because projected current assets increase more than projected current liabilities. Working-capital gap is current assets minus current liabilities. Current assets are estimated at Rs 23.8645 crore for Fiscal 2027, compared with actual restated Rs 17.5416 crore for Fiscal 2026, while current liabilities are estimated at Rs 5.706 crore, compared with Rs 5.0597 crore.

The resulting Fiscal 2027 gap of Rs 18.1585 crore is Rs 5.6766 crore above the Fiscal 2026 actual restated figure of Rs 12.4819 crore. Fiscal 2026 had already recorded a larger gap than Fiscal 2025’s Rs 7.71 crore. Phychem says expected growth in operations will require incremental working capital and that the proposed funding will also release internal accruals deployed in working capital.

Trade receivables and inventories account for much of the projected increase in current assets. Trade receivables are estimated to increase by Rs 2.966 crore, from Rs 5.8333 crore in Fiscal 2026 to Rs 8.7993 crore in Fiscal 2027. Inventories are estimated to increase by Rs 1.5185 crore, from Rs 9.5275 crore to Rs 11.046 crore over the same period.

How do longer customer credit and faster supplier payments increase the gap?

Phychem estimates trade receivable days of 40 for Fiscal 2027, up from 38 days in Fiscal 2026. Trade receivable days measure the average period customers take to settle invoices. Historical receivable days ranged from 33 days to 38 days between Fiscal 2024 and Fiscal 2026, and Phychem says it plans to extend customer credit to support sales growth and customer relationships.

The Fiscal 2027 assumption is seven days above Fiscal 2025’s 33 days and four days above Fiscal 2024’s 36 days. More credit time can leave a greater share of revenue unpaid at a given date, increasing the cash tied up in receivables. The sales-growth rationale depends on extended credit producing additional sales and customers settling within the estimated 40-day period.

Phychem also estimates trade payable days of 25 in Fiscal 2027, down from 29 days in Fiscal 2026. Trade payable days measure the average time taken to pay suppliers. The 25-day estimate is below the historical range of 29 days to 33 days reported for Fiscal 2024 through Fiscal 2026.

Phychem says faster supplier settlement is intended to help it obtain competitive raw-material prices, negotiate favourable supplier terms and maintain supply-chain continuity. Reducing payable days by four days means suppliers would provide less short-term operating finance than in Fiscal 2026. The intended benefit depends on suppliers providing the anticipated pricing or terms while Phychem maintains the planned payment schedule.

What does the inventory estimate contribute to Phychem’s funding need?

Phychem estimates inventory holding of 50 days for Fiscal 2027, compared with 62 days in Fiscal 2026. Inventory includes raw materials and finished goods. The 50-day assumption remains above Fiscal 2025’s 45 days and Fiscal 2024’s 35 days, with Phychem stating that it intends to maintain a buffer against supply-chain disruption while expanding operations.

The lower holding-day assumption does not reduce the forecast inventory balance because the company expects higher operating activity. Inventories are estimated at Rs 11.046 crore in Fiscal 2027, compared with Rs 9.5275 crore in Fiscal 2026. Between those periods, receivable days rise by two days, payable days fall by four days and inventory days fall by 12 days, but the projected balance-sheet figures still result in a larger working-capital gap.

How will Phychem fund its Fiscal 2027 working-capital requirement?

Phychem proposes to use Rs 3 crore of net IPO proceeds in Fiscal 2027 for working-capital requirements. The allocation represents about 17% of the estimated Rs 18.1585 crore gap, rather than the full requirement. The stated purpose is to fund incremental working-capital needs and release internal accruals used in working capital.

Internal accruals are estimated at Rs 15.1015 crore for Fiscal 2027, compared with Rs 7.2552 crore in Fiscal 2026. Short-term borrowings are estimated at Rs 5.70 lakh, compared with Rs 5.2267 crore in Fiscal 2026. The stated Fiscal 2027 funding pattern therefore consists of Rs 15.1015 crore of internal accruals, Rs 3 crore of IPO proceeds and Rs 5.70 lakh of short-term borrowings.

Phychem says it ordinarily funds most working-capital requirements through bank facilities and internal accruals. It also states that any funding shortfall will be met through internal accruals or unsecured loans. As of the red herring prospectus date, Phychem had not raised bridge loans proposed to be repaid from net proceeds, although it may consider secured or unsecured bridge financing if business requirements arise.

What could change in Phychem’s working-capital plan?

Phychem’s Fiscal 2027 working-capital estimate has not been appraised by a bank, financial institution or independent third party. The company says the use of proceeds and funding requirements are based on management estimates and available quotations, and may change with interest-rate structures, financial condition, commercial conditions, business circumstances or strategy.

Phychem’s Board and management will monitor net-issue-proceeds use through the audit committee. Under Regulation 32 of the Securities and Exchange Board of India Listing Regulations, Phychem plans to disclose application of issue proceeds to the audit committee on a half-yearly basis and place an annual statement of funds used for purposes other than those stated in the prospectus before the committee until all proceeds are used.

Conclusion

Phychem’s Rs 3 crore IPO allocation is tied to a specific Fiscal 2027 operating-cycle estimate. The projected Rs 18.1585 crore gap reflects increased current assets, including Rs 8.7993 crore of receivables and Rs 11.046 crore of inventory, alongside an assumption of longer customer credit and faster supplier payments.

The next disclosed measures to watch are Fiscal 2027 receivable days, payable days and inventory days against the 40-day, 25-day and 50-day estimates. If the stated funding requirement is insufficient, Phychem says it may use internal accruals or unsecured loans; a variation in issue objects would require shareholder approval by special resolution under Section 27 of the Companies Act, 2013.